Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination
-
- STATUS
- Recruiting
-
- End date
- Feb 25, 2022
-
- participants needed
- 600
-
- sponsor
- Kirby Institute
Summary
A community-based "test and treat" intervention integrating point-of-care HCV RNA testing, non-invasive liver disease assessment and linkage to care will lead to a reduction in HCV prevalence among people attending Aboriginal health services.
Description
SCALE-C is an interventional cohort study recruiting people with or at risk of HCV infection from Aboriginal health services in Australia. Participants will be screened for HCV infection using point-of-care testing (anti-HCV antibody and/or HCV RNA). People with current HCV infection (HCV RNA positive) will be offered treatment with eight or 12 weeks of pan-genotypic DAA therapy, glecaprevir/pibrentasvir or sofosbuvir/velpatasvir, as available on the PBS.
Details
| Condition | Hepatitis A, LIVER DISEASE, Hepatitis, Hepatitis C, Hepatitis C virus, RNA Virus Infections, Hepatitis, Viral, Human, Viral infection, Digestive System Disease, Liver Disorders, Viral Infections, hepatic disease, hepatopathy, liver diseases, hepatic diseases, hepatic pathology, digestive disorders, digestive diseases, digestive disorder, digestive disease, acute hepatitis a, a hepatitis |
|---|---|
| Treatment | Glecaprevir/Pibrentasvir, Fingerstick GeneXpert HCV RNA quantitative assay, sofosbuvir/velpatesvir |
| Clinical Study Identifier | NCT03776760 |
| Sponsor | Kirby Institute |
| Last Modified on | 25 January 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer